The hemp industry has been waiting with bated breath for the release of the U.S. Food and Drug Administration’s Cannabidiol Enforcement Policy Draft Guidance. FDA sent the draft to the White House Office of Management and Budget last July. Of all FDA documents currently under review at the OMB, the CBD policy has been pending…
Read more
The Food and Drug Administration (FDA) announced on Friday that it will be taking steps in the coming months to fill gaps in research about the safety and efficacy of CBD. Since hemp and its derivatives like cannabidiol were federally legalized under the 2018 Farm Bill, FDA has been developing regulations for products containing them.…
Read more
By Dr. Edele Grey, DVM Vets are being asked more and more by clients about cannabidiol (CBD) oil and whether it may help their fur-babies. Given the recent positive publicity of CBD oil in human medicine it’s a natural progression to want to provide these same benefits for ailing pets; particularly those with painful diseases.…
Read more
Katie Shapiro | Senior Contributor As a new decade begins, the beauty industry’s infatuation with cannabis continues. CBD as a skincare ingredient has proved it’s much more than just the next trend thanks to conscious, clean beauty companies like Saint Jane, which on January 10, will debut in 281 Sephora stores in 22 states across America.…
Read more
By DON JENKINS Capital Press | Jan 9, 2020 OLYMPIA — Hemp’s popular non-psychoactive compound CBD would be a legal food ingredient in Washington under a bill introduced Jan. 7 by a state legislator, a move that would cross federal food-safety regulators. The legislation, sponsored by Republican Rep. Drew MacEwen of Mason County, also runs…
Read more
By Melissa Kress – 11/12/2019 NEW YORK — Cannabis. Marijuana. CBD. Hemp. These terms are being tossed around a lot lately as retailers and consumer packaged goods (CPG) companies look to capitalize on an emerging category. In a recent webcast entitled “Where Cannabis & CPG Collide: How to Prepare Your Business,” Nielsen executives sought to help retailers and CPG companies get down…
Read more
By Rich Maturo, Vice President, Cannabis Practice, Nielsen Activities initiated by the Food and Drug Administration (FDA) will continue to affect the evolving hemp-based CBD marketplace in the U.S. over the next decade. As cannabis-curious consumers and companies wait for additional guidelines from federal regulators, Nielsen believes that brands, marketers and consumers will have a big…
Read more
Posted by Hawkemedia There are certain best practices that apply to marketing consumer brands. With advertising restrictions on major digital platforms, a stampede of products hitting the market, and a lack of true customer understanding, CBD marketing is a challenge all its own. Brands are finding alternative ways to advertise CBD products through organic content, but there’s more to…
Read more
On Dec. 5, the National Association of County Behavioral Health & Developmental Disability Directors (NACBHDD), together with the National Association for Rural Mental Health (NARMH) and the National Association of Social Workers (NASW), hosted a Congressional briefing for Hill staff on the need for improved regulation of cannabidiol (CBD) products by the Food and Drug…
Read more
The Food and Drug Administration’s consumer update on cannabidiol might appear damning, but investors can still profit from CBD’s growth. Although marijuana stocks have been a hot investing trend for years, perhaps nothing eclipses the excitement that’s surrounded cannabidiol (CBD), the nonpsychoactive cannabinoid found in cannabis and hemp that’s best known for its perceived medical benefits. According…
Read more
The FDA’s upcoming decision on CBD CBD sales of hemp-CBD have been increasing at a furious pace – CBD can be found just about everywhere, from gas stations to grocery stores. But this has not been endorsed by the FDA, so sales remain in a grey area under current Federal law. The only FDA-approved CBD product on the…
Read more
Prescription medications, especially ones for anxity and depression have the worst long term effects on your brain. There are so many chemicals and unnatural fillers added to them. Most of the people I’ve come across that went for years relying on a daily dose of Buspirone or beta-blockers to keep them from hiding in the…
Read more
LeafLink, a wholesale marketplace for the cannabis industry, said today it’s closed a $35 million Series B round of funding led by Joshua Kushner’s Thrive Capital. The company claims the round marks “the largest tech B round in the cannabis industry.” It also represents Thrive’s first marijuana investment, according to LeafLink. Current investors London-based Nosara Capital…
Read more
Federal regulations haven’t been issued for CBD yet, but that’s not stopping Americans from utilizing the cannabis compound, according to a survey released by Gallup on Wednesday. In fact, one-in-seven Americans (14 percent) report using some form of CBD, primarily for therapeutic purposes. The poll, which involved phone interviews with more than 2,500 adults from…
Read more
New Jersey Sen. Robert Menendez (D) has introduced legislation to ensure cannabis businesses can access property, casualty, and title insurance. The Clarifying Law Around Insurance of Marijuana (CLAIM) Act, has bipartisan support in the Senate including Democrat Jeff Merkley (OR) and Republicans Rand Paul (KY) and Kevin Cramer (ND) as co-sponsors. The bill would perform…
Read more
The cannabis industry received a wake-up call when the news emerged that the Food and Drug Administration (“FDA”) had issued a warning letter (“Warning Letter”) to Curaleaf, Inc. (“Curaleaf”) for selling products containing cannabidiol (CBD) with unsubstantiated claims. While the FDA has issued warning letters in the past, the Warning Letter marks a milestone because…
Read more
Like with medical marijuana, the wonderful world of CBD can be slightly overwhelming for a newbie and with the mainstream media going crazy for its health benefits, more and more companies are popping up selling a variety of different CBD products, such as CBD vape, sweet CBD candy, the vape pen, capsules, CBD gummies, and other CBD edibles, CBD isolate,…
Read more
The medical and recreational marijuana industries continue to thrive in Massachusetts, with adult-use gross sales totaling $163 million since retailers first opened in November 2018, according to the Massachusetts Cannabis Control Commission. To accompany the fast-moving legalization of medical and adult-use cannabis in the state and across the country, Clark University announced it is launching…
Read more
It’s common these days to hear about a food or beverage company investing in cannabis. It’s more unusual for a cannabis company to, say, snap up a soda brand. In recent months, an emerging cannabis firm has quickly acquired a significant position in Jones Soda (JSDA) with an eye on bringing the wild child of…
Read more
Cannabis stocks were mostly higher on Monday, after the U.S. Food and Drug Administration said it is expediting its effort to create a regulatory framework for CBD with plans to publish a report on its progress by early fall. Amy Abernathy, acting chief information officer, said in a series of tweets sent on Friday that…
Read more
EXO CP, LLC © 2023 All Rights Reserved Copyright.
